Affecting approximately 50% of patients with diabetes, DN is predominantly characterized by distal symmetric polyneuropathy, leading to sensory loss, pain, and motor dysfunction, often resulting in diabetic foot ulcers and lower-limb amputations
Semaglutide 2.4 mg weekly can produce ~1520% body weight reduction over 68 weeks ( [11] )
Horii T et al
A University of Mississippi-led study found that insurers would have to offer more services than just the medication to produce long-term cost savings
After injection, appropriate pressure should be applied to the injection site to prevent bleeding and leakage of the medication
Preclinical studies have shown that ferroptosis-preventing therapies, such as the GSH precursor N-acetylcysteine (NAC), iron-chelating agents like deferoxamine (DFO) and deferiprone (DFP), and specific ferroptosis inhibitors like ferrostatin-1 (Fer-1), can alleviate neurodegeneration and improve motor symptoms in PD animal models (2729)